Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes is a research paper published in JCI Insight (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 1K99CA230201
NIH
Grant: R01CA175732-01
NCI NIH HHS
Grant: R00 CA230201
NCI NIH HHS
Grant: R01 CA175732
NCI NIH HHS
Grant: K99 CA230201
National Institutes of Health
Grant: 1R01CA175732-01
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
National Institutes of Health
Grant: 5K99CA230201-02
Elucidating the Contextual Roles of IL-10 in Patient Response to Cancer Immunotherapy
FWCI
0.99
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals